Aspirin Can Reduce the Risk of Pancreatic Cancer

Based on a research report recently published in the journal Cancer Epidemiology, Biomarkers & Prevention, it was found that regular intake of low dose of aspirin can substantially reduce the risk of pancreatic cancer.

With fatality rate as high as 93 per cent, treatment of pancreatic cancer is considered to be one of the most difficult challenges in the field of Oncology.

"Using low-dose aspirin seems to cut the risk of pancreatic cancer by half," said Harvey Risch, professor of epidemiology at Yale University in Connecticut. "We saw significant reductions in risk with short-term usage as well as with long-term usage."

He also added that "although in some cases, the risk of taking aspirin everyday would outweigh the benefit in pancreatic cancer, for the small numbers of people with strong family histories of pancreatic cancer or who otherwise have been evaluated to be at increased risk of pancreatic cancer, aspirin use could be part of a regimen designed to reduce their risk."
Previously it was reported that Aspirin intake offers prevention against cardiovascular diseases.

But at the same time, aspirin is known to have several side effects. Aspirin makes blood platelets less sticky, which in turn, causes deficient blood clotting. As a result it can significantly reduce the risk of heart attack and stroke, on the other hand, improper usage of this very same aspirin could lead to a situation where bursting of blood vessels in the brain occurs and that proves to be more dangerous a medical condition. Aspirin also increases the risk of stomach bleeding which may turn fatal.

Till now the researcher couldn't come up with any direct and definite link between this daily intake of aspirin and reduced risk of pancreatic cancer.

Therefore, as of now, it is strongly recommended that one shouldn't increase aspirin intake without proper medical consultation.